Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
Oncotarget|April 19, 2017
Lithium protects hippocampal progenitors, cognitive performance and hypothalamus-pituitary function after irradiation to the juvenile rat brainKai Zhou, Cuicui Xie, Malin Wickström, et al.
Genes, Chromosomes & Cancer|July 25, 2019
Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangementsNiloufar Javanmardi, Susanne Fransson, Anna Djos, et al.
International Journal of Cancer|September 6, 2012
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivoMalin Wickström, Cecilia Dyberg, Takashi Shimokawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppressionIsabelle Westerlund, Yao Shi, Konstantinos Toskas, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 8, 2026
Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53)Alexander Sun Zhang, Meis Omran, Joakim Wille, et al.
Neuro-Oncology|August 22, 2008
Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targetsNinib Baryawno, Baldur Sveinbjörnsson, Staffan Eksborg, et al.
Oncotarget|December 10, 2017
Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability <i>in vitro</i> and impairs tumor growth <i>in vivo</i>Conny Tümmler, Igor Snapkov, Malin Wickström, et al.
Journal of Molecular Neuroscience : MN|September 7, 2006
Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide geneRadmila Santic, Katrin Fenninger, Kerstin Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivoFrida Ponthan, Malin Wickström, Helena Gleissman, et al.
Ebiomedicine|May 29, 2018
Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor GrowthAnna Kock, Karin Larsson, Filip Bergqvist, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Oncotarget|April 19, 2017
Lithium protects hippocampal progenitors, cognitive performance and hypothalamus-pituitary function after irradiation to the juvenile rat brainKai Zhou, Cuicui Xie, Malin Wickström, et al.
Genes, Chromosomes & Cancer|July 25, 2019
Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangementsNiloufar Javanmardi, Susanne Fransson, Anna Djos, et al.
International Journal of Cancer|September 6, 2012
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivoMalin Wickström, Cecilia Dyberg, Takashi Shimokawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppressionIsabelle Westerlund, Yao Shi, Konstantinos Toskas, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 8, 2026
Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53)Alexander Sun Zhang, Meis Omran, Joakim Wille, et al.
Neuro-Oncology|August 22, 2008
Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targetsNinib Baryawno, Baldur Sveinbjörnsson, Staffan Eksborg, et al.
Oncotarget|December 10, 2017
Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability <i>in vitro</i> and impairs tumor growth <i>in vivo</i>Conny Tümmler, Igor Snapkov, Malin Wickström, et al.
Journal of Molecular Neuroscience : MN|September 7, 2006
Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide geneRadmila Santic, Katrin Fenninger, Kerstin Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivoFrida Ponthan, Malin Wickström, Helena Gleissman, et al.
Ebiomedicine|May 29, 2018
Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor GrowthAnna Kock, Karin Larsson, Filip Bergqvist, et al.
Pageof 17